Amylyx Pharmaceuticals, Inc. ($AMLX)
Filing Information
| Accession Number | 0001193125-26-380152 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
100,000
Total Value
$170,250.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 31, 2026 | Exercise/Conversion | 25,000 | $1.76 | $44,000.00 | 91,900 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 31, 2026 | Exercise/Conversion | 25,000 | $5.05 | $126,250.00 | 116,900 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Aug 31, 2026 | Exercise/Conversion | 25,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Aug 31, 2026 | Exercise/Conversion | 25,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |